NEA 14 GP, LTD
CIK 1551532 · last filed 2022-01-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.15B
Companies
7
Total Filings
17
Lifetime Open-Market Net
$200.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMRA | 10%+ Owner | 3,476,421 | $17.02 | $59.17M | -$912.1K | 2 | 2022-01-14 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 5,959,520 | $29.08 | $173.30M | $0 | 2 | 2020-09-16 |
| Casper Sleep Inc. (CSPR) Delisted | 10%+ Owner | 6,222,412 | $6.78 | $42.19M | $105.00M | 1 | 2020-02-12 |
| ASND | 10%+ Owner | 82,978,668 | $218.06 | $18.09B | $87.04M | 4 | 2018-09-10 |
| APPN | 10%+ Owner | — | $24.01 | — | $0 | 1 | 2017-05-31 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $9.00M | 1 | 2014-08-06 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-03-23 | ASND | Buy (P) | +3,805,524 | $7.25M | EDGAR |
| 2017-05-31 | APPN | Conv (C) | — | $0 | EDGAR |
| 2017-03-28 | ASND | Buy (P) | +38,610,000 | $27.03M | EDGAR |
| 2015-10-20 | Avalo Therapeutics, Inc. (CERC.U) Delisted | Conv (C) | +1,782,735 | $0 | EDGAR |
| 2014-12-29 | — | Buy (P) | +79,475,860 | $7.97M | |
| 2014-08-06 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | +5,368,260 | $9.00M | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.